

FcγIII receptor expression and neutrophil granularity as prognostic biomarkers for infectious complications in newborns
https://doi.org/10.21508/1027-4065-2024-69-6-43-50
Abstract
Neonatal sepsis remains a pressing issue for healthcare both in Russia and globally due to its high mortality rate and resistance to treatment. Infection generalization in newborns is facilitated by a deficiency in innate immunity, which is particularly evident in impaired neutrophil function.
The aim of this study was to identify phenotypic characteristics of specific neutrophil subsets that could be significant in predicting the development and progression of infection in newborns. Using flow cytometry, we examined CD16 and CD62L expression as well as neutrophil granularity in newborns across three groups: those without infectious complications (n=38), with localized infection (n=32), and with generalized infection (n=21). Neutrophil subsets with high and intermediate levels of CD16 and CD62L expression demonstrated prognostic relevance. Patients with generalized infection exhibited a significant reduction in surface CD16 and granularity in these neutrophil subsets. Cutoff points were calculated, showing that a decrease in these parameters on the first day of illness was significantly associated with extended stays in intensive care units and overall hospitalization duration. The proposed indicators show promise for predicting infectious complications in newborns, facilitating more targeted and proactive care in neonatal practice.
About the Authors
I. V. ObraztsovRussian Federation
Moscow
A. A. Kopteva
Russian Federation
Moscow
A. A. Obraztsova
Russian Federation
Moscow
E. V. Chernikova
Russian Federation
Moscow
O. V. Voronina
Russian Federation
Moscow
N. V. Davydova
Russian Federation
Moscow
L. A. Fedorova
Russian Federation
Moscow
Yu. V. Zhirkova
Russian Federation
Moscow
A. A. Korsunskiy
Russian Federation
Moscow
I. I. Afukov
Russian Federation
Moscow
References
1. Shane A.L., Sánchez P.J., Stoll B.J. Neonatal sepsis. Lancet 2017; 390(10104): 1770–1780. DOI: 10.1016/S0140–6736(17)31002–4
2. Boscarino G., Migliorino R., Carbone G., Davino G., Dell’Orto V.G., Perrone S. et al. Biomarkers of Neonatal Sepsis: Where We Are and Where We Are Going. Antibiotics (Basel) 2023; 12(8): 1233. DOI: 10.3390/antibiotics12081233
3. Pleskova S.N., Erofeev A.S., Vaneev A.N., Gorelkin P.V., Bobyk S.Z., Kolmogorov V.S. et al. ROS Production by a Single Neutrophil Cell and Neutrophil Population upon Bacterial Stimulation. Biomedicines 2023; 11(5): 136. DOI: 0.3390/biomedicines11051361
4. Ashchina L.A., Baranova N.I., Bolgova A.I. Pokazateli funkcional’noj aktivnosti nejtrofilov kak prediktory tyazhesti COVID-19. Immunopatologiya, allergologiya, infektologiya 2023; 2: 52–55. (in Russ.) DOI: 10.14427/jipai.2023.2.52
5. Pivovarova L.P., Osipova I.V., Ariskina O.B., Orlova O.V. Neutrophil granulocytes in patients with burn injury. Meditsinskaya immunologiya 2023; 25(2): 403–408. (in Russ.) DOI: 10.15789/10.15789/1563–0625-NGI-2327
6. Shen X.F., Cao K., Jiang J.P., Guan W.X., Du J.F. Neutrophil dysregulation during sepsis: an overview and update. J Cell Mol Med 2017; 21(9): 1687–1697. DOI: 10.1111/jcmm.13112
7. Hanna M.O.F., Abdelhameed A.M., Abou-Elalla A.A., Hassan R.M., Kostandi I. Neutrophil and monocyte receptor expression in patients with sepsis: implications for diagnosis and prognosis of sepsis. Pathog Dis 2019; 77(6): ftz055. DOI: 10.1093/femspd/ftz055
8. Bongers S.H., Chen N., van Grinsven E., van Staveren S., Hassani M., Spijkerman R. et al. Kinetics of Neutrophil Subsets in Acute, Subacute, and Chronic Inflammation. Front Immunol 2021; 12: 674079. DOI: 10.3389/fimmu.2021.674079
9. Medara N., Lenzo J.C., Walsh K.A., Reynolds E.C., O’Brien-Simpson N.M., Darby I.B. Peripheral neutrophil phenotypes during management of periodontitis. J Periodontal Res 2021; 56(1): 58–68. DOI: 10.1111/jre.12793
10. Fraser J.A., Kemp S., Young L., Ross M., Prach M., Hutchison G.R., Malone E. Silver nanoparticles promote the emergence of heterogeneic human neutrophil sub-populations. Sci Rep 2018; 8(1): 7506. Published 2018 May 14. DOI: 10.1038/s41598–018–25854–2
11. Pillay J., Kamp V.M., Van Hoffen E., Visser T., Tak T., Lammers J.W. et al. A Subset of Neutrophils in Human Systemic Inflammation Inhibits T Cell Responses Through Mac-1. J Clin Invest 2012; 122(1): 327–336. DOI: 10.1172/JCI57990
12. Hesselink L., Spijkerman R., de Fraiture E., Bongers S., Van Wessem K.J.P., Vrisekoop N. et al. New Automated Analysis to Monitor Neutrophil Function Point-of-Care in the Intensive Care Unit After Trauma. Intensive Care Med Exp 2020; 8: 12. DOI: 10.1186/s40635–020–0299–1
13. Leliefeld P.H.C., Pillay J., Vrisekoop N., Heeres M., Tak T., Kox M. et al. Differential Antibacterial Control by Neutrophil Subsets. Blood Adv 2018; 2: 1344–1355. DOI: 10.1182/bloodadvances.2017015578
14. Zhang J., Gao C., Zhu Z., Li D., Qu L., Xue Q. et al. New findings on CD16brightCD62Ldim neutrophil subtypes in sepsis-associated ARDS: an observational clinical study. Front Immunol 2024; 15: 1331050. DOI: 10.3389/fimmu.2024.1331050
Review
For citations:
Obraztsov I.V., Kopteva A.A., Obraztsova A.A., Chernikova E.V., Voronina O.V., Davydova N.V., Fedorova L.A., Zhirkova Yu.V., Korsunskiy A.A., Afukov I.I. FcγIII receptor expression and neutrophil granularity as prognostic biomarkers for infectious complications in newborns. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2024;69(6):43-50. (In Russ.) https://doi.org/10.21508/1027-4065-2024-69-6-43-50